Neurology Medical News about encephalomyelitis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Reciprocal effect of mesenchymal stem cell on experimental autoimmune encephalomyelitis is mediated by transforming growth factor-beta and interleukin-6
Clinical and Experimental Immunology, 09/04/09

Liu XJ et al. – The authors demonstrate that MSCs have the capacity for either stimulating or inhibiting myelin basic protein–specific T lymphocytes in a dose–dependent manner and modulate antigen–stimulated T cells to differentiate into either T helper type 17 or regulatory T cells, respectively, via pathways involving transforming growth factor–? and interleukin–6. These results may lead better utility of MSCs as a treatment for autoimmune disease.

<< Previous
Clinical phenotype of autosomal dominant progressive external...

Next >>
Association between altered systemic inflammatory...